Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 3:10:1175731.
doi: 10.3389/fcvm.2023.1175731. eCollection 2023.

Type 2 diabetes and in-hospital sudden cardiac arrest in ST-elevation myocardial infarction in the US

Omar Mhaimeed  1   2 , Krishnadev Pillai  2 , Soha Dargham  3 , Jassim Al Suwaidi  4 , Hani Jneid  5 , Charbel Abi Khalil  2   4   6
Affiliations

Type 2 diabetes and in-hospital sudden cardiac arrest in ST-elevation myocardial infarction in the US

Omar Mhaimeed et al. Front Cardiovasc Med. .

Abstract

Aims: We aimed to assess the impact of diabetes on sudden cardiac arrest (SCA) in US patients hospitalized for ST-elevation myocardial infarction (STEMI).

Methods: We used the National Inpatient Sample (2005-2017) data to identify adult patients with STEMI. The primary outcome was in-hospital SCA. Secondary outcomes included in-hospital mortality, ventricular tachycardia (VT), ventricular fibrillation (VF), cardiogenic shock (CS), acute renal failure (ARF), and the revascularization strategy in SCA patients.

Results: SCA significantly increased from 4% in 2005 to 7.6% in 2018 in diabetes patients and from 3% in 2005 to 4.6% in 2018 in non-diabetes ones (p < 0.001 for both). Further, diabetes was associated with an increased risk of SCA [aOR = 1.432 (1.336-1.707)]. In SCA patients with diabetes, the mean age (SD) decreased from 68 (13) to 66 (11) years old, and mortality decreased from 65.7% to 49.3% during the observation period (p < 0.001). Compared to non-diabetes patients, those with T2DM had a higher adjusted risk of mortality, ARF, and CS [aOR = 1.72 (1.62-1.83), 1.52 (1.43-1.63), 1.25 (1.17-1.33); respectively] but not VF or VT. Those patients were more likely to undergo revascularization with CABG [aOR = 1.197 (1.065-1.345)] but less likely to undergo PCI [aOR = 0.708 (0.664-0.754)].

Conclusion: Diabetes is associated with an increased risk of sudden cardiac arrest in ST-elevation myocardial infarction. It is also associated with a higher mortality risk in SCA patients. However, the recent temporal mortality trend in SCA patients shows a steady decline, irrespective of diabetes.

Keywords: ST elevation myocardial infarction; cardiovascular disease; diabetes; mortality; sudden cardiac arrest.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study.
Figure 2
Figure 2
Temporal changes of in-hospital sudden cardiac arrest in patients with diabetes (red color) and without diabetes (blue color). The X-axis represents the percentage of sudden cardiac arrest. The Y-axis represents the year.
Figure 3
Figure 3
Temporal change of in-hospital mortality in patients with sudden cardiac arrest and diabetes (red color) and without diabetes (blue). The X-axis represents the percentage of sudden mortality. The Y-axis represents the year.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Zimmerman DS, Tan HL. Epidemiology and risk factors of sudden cardiac arrest. Curr Opin Crit Care. (2021) 27:613–6. 10.1097/MCC.0000000000000896 - DOI - PubMed
    1. Koivunen M, Tynkkynen J, Oksala N, Eskola M, Hernesniemi J. Incidence of sudden cardiac arrest and sudden cardiac death after unstable angina pectoris and myocardial infarction. Am Heart J. (2022) 257:9–19. 10.1016/j.ahj.2022.11.009 - DOI - PubMed
    1. Okin PM, Kjeldsen SE, Julius S, Dahlof B, Devereux RB. Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study. Heart Rhythm. (2012) 9:531–7. 10.1016/j.hrthm.2011.11.008 - DOI - PubMed
    1. Jimenez-Pavon D, Artero EG, Lee DC, Espana-Romero V, Sui X, Pate RR, et al. Cardiorespiratory fitness and risk of sudden cardiac death in men and women in the United States: a prospective evaluation from the aerobics center longitudinal study. Mayo Clin Proc. (2016) 91:849–57. 10.1016/j.mayocp.2016.04.025 - DOI - PubMed
    1. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. (2018) 72:e91–e220. 10.1016/j.jacc.2017.10.054 - DOI - PubMed